April 17, 2018
Exosome Diagnostics Obviates Tissue Biopsies
March 21, 2018
Exosome Diagnostics Appoints Accomplished Urologist, Grannum Sant, MD, FRCS, FACS, as Head of Medical Affairs
March 20, 2018
Exosome Diagnostics Announces Publication of a Highly Sensitive Exosome Based Liquid Biopsy Test for EGFR T790M Mutations in Plasma from Non-Small Cell Lung Cancer Patients
March 13, 2018
Exosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) Inhibitor
February 23, 2018
Exosome Diagnostics Expands its Coverage Reach for EPI to an Additional 82 Million Covered Lives in the United States
February 1, 2018
Exosome Diagnostics Significantly Expands Access and Coverage for its EPI Prostate Cancer Test through Agreement with FedMed
January 25, 2018
Exosome Diagnostics Executes Agreement with America’s Choice Provider Network Expanding Access and Coverage for EPI to 28 Million Member Network in the US
January 9, 2018
Exosome Diagnostics Places Early Access Shahky™ Exosomal Protein Detection System at MGH Center for Systems Biology
January 8, 2018
Exosome Diagnostics Announces Positive Coverage for EPI from Largest Payor in the Mid-Atlantic Region
January 8, 2018
Exosome Diagnostics Places Its First Early Access Shahky System within a Top 15 Pharmaceutical Laboratory
January 4, 2018
Exosome Diagnostics Launches National Sales Team to Support Flagship Test, ExoDx®Prostate(IntelliScore)
December 19, 2017
Exosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung Cancer
December 4, 2017
Exosome Diagnostics Executes Coverage Agreement for its EPI Test with Three Rivers Provider Network
November 27, 2017
November 13, 2017
October 11, 2017
September 19, 2017
August 9, 2017
Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel
August 3, 2017
Exosome Diagnostics Achieves ISO 13485 Certification
August 1, 2017
Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
July 24, 2017
Exosome Diagnostics Completes $30 Million Series C Financing
June 22, 2017
Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention
May 31, 2017
UPCOMING EVENTS
Now available to Heathcare Providers for Clinical Use: The Industry’s First Exosome-Based Liquid Biopsy Tests
Order Here
The Industry’s First RNA-Based Liquid Biopsies
We are bringing the first exosome-based diagnostics to market. Learn more about our Laboratory Developed Tests, which will be analyzed in our CLIA-certified laboratory:
